Literature DB >> 11946500

Inactivation of human erythrocyte carbonic anhydrases by bromopyruvate.

P O. Göthe1, P O. Nyman.   

Abstract

Entities:  

Year:  1972        PMID： 11946500     DOI： 10.1016/0014-5793(72)80127-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  5 in total

1.  Carbonic anhydrase II deficiency: diagnosis and carrier detection using differential enzyme inhibition and inactivation.

Authors:  V Sundaram; P Rumbolo; J Grubb; P Strisciuglio; W S Sly
Journal:  Am J Hum Genet       Date:  1986-02       Impact factor: 11.025

Review 2.  The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside.

Authors:  J Azevedo-Silva; O Queirós; F Baltazar; S Ułaszewski; A Goffeau; Y H Ko; P L Pedersen; A Preto; M Casal
Journal:  J Bioenerg Biomembr       Date:  2016-07-25       Impact factor: 2.945

3.  The catalytic mechanism of carbonic anhydrase.

Authors:  S Lindskog; J E Coleman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-09       Impact factor: 11.205

Review 4.  Regulation of bacterial glycogen synthesis.

Authors:  J Preiss; S G Yung; P A Baecker
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

5.  MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors.

Authors:  Kivanç Birsoy; Tim Wang; Richard Possemato; Omer H Yilmaz; Catherine E Koch; Walter W Chen; Amanda W Hutchins; Yetis Gultekin; Tim R Peterson; Jan E Carette; Thijn R Brummelkamp; Clary B Clish; David M Sabatini
Journal:  Nat Genet       Date:  2012-12-02       Impact factor: 38.330
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.